• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 5-(3-METHYLPHENYL)-5-OXOVALERIC ACID (CAS No. 36978-51-5)

5-(3-Methylphenyl)-5-oxovaleric acid, identified by the Chemical Abstracts Service Number (CAS No.) 36978-51-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, featuring a valeric acid moiety substituted with an oxo group and an aromatic ring at the 3-position, has garnered attention due to its structural versatility and potential biological activities. The presence of a 3-methylphenyl group introduces a unique electronic and steric environment, making it a valuable scaffold for medicinal chemistry investigations.

The compound's structure consists of a five-carbon chain with a carboxylic acid group at one end and an oxo group (C=O) at the fifth carbon, which is further substituted with a phenyl ring bearing a methyl group at the 3-position. This arrangement imparts specific chemical properties that make it useful in various synthetic applications. The 5-oxovaleric acid core is reminiscent of known bioactive molecules, suggesting potential interactions with biological targets.

In recent years, there has been growing interest in exploring the pharmacological properties of structurally diverse carboxylic acids. The 3-methylphenyl substituent enhances the molecule's lipophilicity, which can be advantageous for membrane permeability and target binding. This feature has prompted researchers to investigate its potential as an intermediate in drug development, particularly in the synthesis of novel therapeutic agents.

One of the most compelling aspects of 5-(3-methylphenyl)-5-oxovaleric acid is its utility as a building block in organic synthesis. The combination of the oxo group and the aromatic ring provides multiple reactive sites for further functionalization. For instance, the carboxylic acid group can be esterified, amidated, or used in condensation reactions to form more complex molecules. Similarly, the aromatic ring can undergo various transformations, such as halogenation or alkylation, enabling the creation of derivatives with tailored properties.

Recent studies have highlighted the importance of 5-oxovaleric acid derivatives in medicinal chemistry. These compounds have shown promise in modulating various biological pathways, including enzyme inhibition and receptor binding. The 3-methylphenyl moiety, in particular, has been associated with enhanced binding affinity in certain pharmacological contexts. This observation has spurred further investigation into its role in drug design and development.

The synthesis of 5-(3-methylphenyl)-5-oxovaleric acid typically involves multi-step organic reactions starting from commercially available precursors. One common approach involves the condensation of 3-methylbenzaldehyde with diethyl malonate followed by oxidation and hydrolysis to yield the desired product. Alternatively, palladium-catalyzed cross-coupling reactions can be employed to introduce the aromatic ring more efficiently. These synthetic strategies highlight the compound's accessibility and feasibility for large-scale production.

From a computational chemistry perspective, 5-(3-methylphenyl)-5-oxovaleric acid has been studied to understand its molecular interactions and pharmacophoric features. Molecular docking simulations have revealed that this compound can bind to various protein targets with high affinity. The 3-methylphenyl group is particularly important for establishing favorable interactions with hydrophobic pockets in protein binding sites. Additionally, the oxo group contributes to hydrogen bonding capabilities, further enhancing binding specificity.

The pharmaceutical industry has shown interest in exploring derivatives of 5-(3-methylphenyl)-5-oxovaleric acid for their potential therapeutic applications. Researchers are investigating its role in developing treatments for neurological disorders, where modulation of neurotransmitter activity is crucial. Preliminary studies suggest that certain derivatives may exhibit properties similar to known pharmacological agents, making them promising candidates for further development.

In conclusion,5-(3-methylphenyl)-5-oxovaleric acid (CAS No. 36978-51-5) is a versatile compound with significant potential in both synthetic chemistry and pharmaceutical research. Its unique structural features make it an attractive scaffold for designing novel bioactive molecules. The ongoing studies into its pharmacological properties and synthetic applications underscore its importance as a valuable chemical entity in modern drug discovery efforts.

• 2051-95-8(3-Benzoylpropionic acid)
• 57821-78-0(4-Oxo-4-(4-propylphenyl)butanoic Acid)
• 4619-20-9(4-(4-Methylphenyl)-4-oxobutanoic Acid)
• 66147-75-9(7-Oxo-8-phenyloctanoic Acid)
• 1501-05-9(5-Oxo-5-phenylpentanoic acid)
• 16269-05-9(9-Oxo-9-phenylnonanoic acid)
• 24314-23-6(Benzeneoctanoic acid, h-oxo-)
• 7472-43-7(7-Oxo-7-phenylheptanoic acid)
• 49594-75-4(4-Ethyl-γ-oxobenzenebutanoic Acid)
• 4144-62-1(5-Benzoylpentanoic acid)